The Association Between the Rate of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Use and the Number of Covid-19 Confirmed Cases and Deaths in the United States: Geospatial Study

Kyle Johnson, Maedeh Khayyat-Kholghi, Blake Johnson, Larisa G. Tereshchenko
doi: https://doi.org/10.1101/2020.05.31.20118802

Article usage

Article usage: June 2020 to December 2024

AbstractFullPdf
Jun 20207060350
Jul 20204080265
Aug 2020147088
Sep 2020121059
Oct 202074025
Nov 202093097
Dec 202090086
Jan 202194186
Feb 202198074
Mar 20211252118
Apr 20211333112
May 20211414151
Jun 202191430
Jul 202166621
Aug 2021581021
Sep 202136021
Oct 202157538
Nov 202142431
Dec 202143620
Jan 202263823
Feb 202243217
Mar 202228312
Apr 20223117
May 2022281016
Jun 202232212
Jul 20223616
Aug 202230613
Sep 202235012
Oct 20222707
Nov 20221137
Dec 20222939
Jan 202332015
Feb 202321417
Mar 20232005
Apr 202329111
May 20231919
Jun 20231747
Jul 20231914
Aug 202319157
Sep 20231768
Oct 20231303
Nov 202316121
Dec 20231605
Jan 2024505
Feb 20241015
Mar 2024806
Apr 20241084
May 20241987
Jun 20242147
Jul 20242329
Aug 2024836
Sep 20241749
Oct 20241387
Nov 2024915
Dec 2024904
Back to top
Posted June 20, 2020.
Download PDF
Data/Code
Email
The Association Between the Rate of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Use and the Number of Covid-19 Confirmed Cases and Deaths in the United States: Geospatial Study
Kyle Johnson, Maedeh Khayyat-Kholghi, Blake Johnson, Larisa G. Tereshchenko
medRxiv 2020.05.31.20118802; doi: https://doi.org/10.1101/2020.05.31.20118802
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area